Post-approval studies (Phase 4)UnknownNCT01405807
What this trial is testing
Alemtuzumab for ANCA Associated Refractory Vasculitis
Who this might be right for
VasculitisMicroscopic PolyangiitisGranulomatosis With Polyangiitis+1 more
Cambridge University Hospitals NHS Foundation Trust 24